National Center for Research and Development
VC Fund
Warszawa, Poland
National Center for Research and Development is a VC fund in Warszawa focused on Machine Learning and Artificial Intelligence. The National Centre for Research and Development is the implementing agency of the Minister of Science and Higher Education. It was appointed in the summer 2007 as an entity in charge of the performance of the tasks within the area of national science, science and technology and innovation policies. When if was founded, it was the first entity ofthis type, created as the platform of an effective dialogue between the scientific and business communities.Currently, it operates under the Act on National Centre for Research and Development dated 30 April 2010 (Journal of Laws from 2010, No. 96 item 616). The science reform adopted in the autumn 2010 gave the Centre more freedom to manage its financial assets, within the scope of a strategic research programme.In addition, the National Centre for Research and Development extended its activity with new initiatives and possibilities on 1 September 2011. Assigned by the Ministry of Science and Higher Education the function of the Mediation Institution in three operational programmes: Human Capital, Innovative Economy and Infrastructure and Environment, the Centre became one of the greatest innovation centres in Poland. The activity of the Centre is funded by the national treasury and the European Union.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries National Center for Research and Development invests in
Stages National Center for Research and Development invests in
Countries National Center for Research and Development invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1.7M–$2.2M
- Grant
- $1.1M–$2.5M
Investment Focus
Industry
- Machine Learning 3 (33%)
- Artificial Intelligence 3 (33%)
- Big Data 2 (22%)
- Software 2 (22%)
- SaaS 1 (11%)
Stage
- Grant 4 (44%)
- Seed 3 (33%)
- Pre-Seed 1 (11%)
- Funding Round 1 (11%)
Country
- Poland 7 (78%)
- United Kingdom 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Maciej Chorowski
Director
|
Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Alphamoon
|
Alphamoon has developed a technology that reduces the time and cost of document processing by automating it, with the help of state-of-the-art AI methods and NLP. The technology is designed to collect and process data from any kind of document in any format. | $2.2M / Seed / Apr 28, 2022 | |
Labplus
|
Labplus offers medical automated diagnosis based on lab results and personalized medical interview. | $1.7M / Pre-Seed / Dec 01, 2021 | |
sky crops
|
AI-based robots that automatically and independently inspect and spray an orchard for: producer groups, farmers, greenhouses, and agronomists to reduce money waste, chemical usage and grow healthy fruits with high financial profit | $1.7M / Seed / Apr 27, 2021 | |
NeuroSYS
|
We are a bunch of tech enthusiasts who deliver custom IT solutions in a predictable way. We help businesses bring their ideas to life from scratch, as well as rescue ongoing projects.We believe that new technologies will reshape businesses and whole industries as we know them now (let alone our lives!). Willing to be a part of that change we’velaunched R&D department that conducts research and provides services in the field of machine learning and deep learning.Since 2010 we’ve successfully implemented >58 projects for our clients around the world, never constrained by tough deadlines & requirements, distance, technical limitations or lack of imagination. With a focus on quality and efficiency, we keep improving our processes, remaining true to agile principles. | $1.3M / Grant / Nov 18, 2020 | |
StethoMe
|
StethoMe is a digital stethoscope designed for remote monitoring of heart and lung sounds. It connects patients with healthcare professionals, allowing for real-time audio transmission. The device captures and transmits acoustic data, facilitating remote assessments. This technology supports healthcare providers in making informed decisions basedon patient conditions. | $1.2M / Grant / Nov 17, 2020 | |
Pure Biologics
|
Pure Biologics is the Polish leader in in vitro selection technology from antibody libraries and aptamers. They are also one of the few European entities offering research of this type as part of contractual activities. Their knowledge and technical facilities are the basis of our contract research. Their expertise also includes recombinantproteins, protein engineering and characterization. Thanks to this, they can offer their partners a wide range of research and analytical services. | $7.4M / Aug 21, 2019 | |
Billon Group
|
Billon Group is a fintech company that provides an enterprise DLT system for accounts and transactions and targets at bank accounts. The technology is optimized for regulated institutional use as a scalable private, permission DLT (outperforming cryptocurrency adaptations). It is fully regulatory compliant for both money and document applications.Billon offers near real-time settlement of domestic and cross border payments. It also enables fiat money to be digitized and the firm is registered as an e-money issuer in the UK and Poland. The partners with enterprise customers to create DLT based solutions on it’s a full platform. Reusable modules & APIs allow for rapid creation and delivery. The platform combines the blockchain and distributed ledger is built for enterprise implementations and achieved full compliance with data and money regulations.Billon Group was founded in 2015 and is headquartered in London, England, United Kingdom. | $1.1M / Grant / Jun 05, 2018 | |
|
StethoMe
|
StethoMe is a digital stethoscope designed for remote monitoring of heart and lung sounds. It connects patients with healthcare professionals, allowing for real-time audio transmission. The device captures and transmits acoustic data, facilitating remote assessments. This technology supports healthcare providers in making informed decisions basedon patient conditions. | $1.7M / Seed / Aug 01, 2017 | |
XTPL
|
XTPL developed innovative printing-head and dedicated nanoinks that enable ultra-precise printing of nanomaterials. The solution – due to its platform character – will be used in a wide printed electronics sector & provide low-cost, simple, additive manufacturing method for high-tech devices. The technology will facilitate the production of anew generation transparent conductive films (TCF) used in manufacturing of i.e. monitors, touch screens, photovoltaic cells & displays - where XTPL can also deliver the technology for open-defect repair and quantum dots. XTPL solution may also serve as the sought-after alternative for photolithography used, among others, in the semiconductors sector. The company aims to provide unique printing heads - each time designed & dedicated for specific application field - as well as compatible, precisely adjusted nanoinks. | $2.5M / Grant / Jan 12, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does National Center for Research and Development invest in?
National Center for Research and Development invests primarily in Machine Learning, Artificial Intelligence and Big Data startups, most often at Grant and Seed stage. Most of the 9 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is National Center for Research and Development's check size?
National Center for Research and Development typically joins rounds of $1.7M–$2.2M at Seed and $1.1M–$2.5M at Grant. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds National Center for Research and Development participates in.
How do I contact National Center for Research and Development?
Public channels for National Center for Research and Development include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at National Center for Research and Development?
The team at National Center for Research and Development includes Maciej Chorowski (Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
